Year-end Sale % OFF 
Abstract
Recently there has been considerable discussion concerning the analysis of data and presentation of results from clinical trials in breast cancer. A problem stems from there being several events of interest, notably disease recurrence and death. Current methods based on 'so-called' disease-free survival are criticized on the grounds that they confuse events, such as disease recurrence and death, in the treatment comparison and consequently could be very misleading. Alternative methods of analysis, based on separate measures of treatment effect are presented and illustrated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
